Article
Editorial Article
Document
Information Content Entity
Continuant
Continuant
Entity
Entity
Generically Dependent Continuant
2025-06-24T09:31:50
RDF description of Romosozumab versus Alendronate and fracture risk in women with osteoporosis [editorial] - http://repository.healthpartners.com/individual/document-rn2558
378
public
Romosozumab versus Alendronate and fracture risk in women with osteoporosis [editorial]
New England Journal of Medicine
Fractures
Risk Factors
2
document-rn2558
10.1056/NEJMc1714810
26090
Osteoporosis
editorial
2022-02-21T22:48:57.408-06:00
15755
Drugs and Drug Therapy